<?xml version='1.0' encoding='utf-8'?>
<document id="19282398"><sentence text="Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats."><entity charOffset="93-104" id="DDI-PubMed.19282398.s1.e0" text="cyclosporin" /></sentence><sentence text="Cyclosporin A (CsA) is a well known inhibitor of the organic anion-transporting polypeptide (OATP/Oatp) family transporters, causing a large number of transporter-mediated drug-drug interactions in clinical situations"><entity charOffset="0-13" id="DDI-PubMed.19282398.s2.e0" text="Cyclosporin A" /><entity charOffset="15-18" id="DDI-PubMed.19282398.s2.e1" text="CsA" /><pair ddi="false" e1="DDI-PubMed.19282398.s2.e0" e2="DDI-PubMed.19282398.s2.e0" /><pair ddi="false" e1="DDI-PubMed.19282398.s2.e0" e2="DDI-PubMed.19282398.s2.e1" /></sentence><sentence text=" In the present study, we examined the inhibitory effect of CsA on the hepatic uptake of sulfobromophthalein (BSP) in rats, focusing on a long-lasting inhibition"><entity charOffset="60-62" id="DDI-PubMed.19282398.s3.e0" text="CsA" /></sentence><sentence text=" Twenty-one hours after the subcutaneous administration of CsA, the hepatic clearance of BSP was decreased"><entity charOffset="59-61" id="DDI-PubMed.19282398.s4.e0" text="CsA" /></sentence><sentence text=" The liver uptake index study revealed that hepatic uptake of BSP was reduced in CsA-treated rats for at least 3 days"><entity charOffset="81-83" id="DDI-PubMed.19282398.s5.e0" text="CsA" /></sentence><sentence text=" Comparison of uptake studies using isolated hepatocytes prepared from control and CsA-treated rats showed that hepatic uptake in CsA-treated rats was decreased"><entity charOffset="83-85" id="DDI-PubMed.19282398.s6.e0" text="CsA" /><entity charOffset="130-132" id="DDI-PubMed.19282398.s6.e1" text="CsA" /><pair ddi="false" e1="DDI-PubMed.19282398.s6.e0" e2="DDI-PubMed.19282398.s6.e0" /><pair ddi="false" e1="DDI-PubMed.19282398.s6.e0" e2="DDI-PubMed.19282398.s6.e1" /></sentence><sentence text=" In primary cultured hepatocytes, after preincubation with CsA, the uptake of [(3)H]BSP was reduced even after removal of CsA from the incubation buffer although a preincubation time dependence was not observed"><entity charOffset="78-87" id="DDI-PubMed.19282398.s7.e0" text="[(3)H]BSP" /><entity charOffset="59-67" id="DDI-PubMed.19282398.s7.e1" text="CsA" /><entity charOffset="122-130" id="DDI-PubMed.19282398.s7.e2" text="CsA" /><pair ddi="false" e1="DDI-PubMed.19282398.s7.e1" e2="DDI-PubMed.19282398.s7.e1" /><pair ddi="false" e1="DDI-PubMed.19282398.s7.e1" e2="DDI-PubMed.19282398.s7.e0" /><pair ddi="false" e1="DDI-PubMed.19282398.s7.e1" e2="DDI-PubMed.19282398.s7.e2" /><pair ddi="false" e1="DDI-PubMed.19282398.s7.e0" e2="DDI-PubMed.19282398.s7.e0" /><pair ddi="false" e1="DDI-PubMed.19282398.s7.e0" e2="DDI-PubMed.19282398.s7.e2" /></sentence><sentence text=" However, the expression of Oatp1a1 and Oatp1b2, which are involved in the hepatic uptake of BSP, and the amount of intrahepatic glutathione, a driving force of Oatp1a1, did not change in CsA-treated rats"><entity charOffset="129-140" id="DDI-PubMed.19282398.s8.e0" text="glutathione" /><entity charOffset="188-198" id="DDI-PubMed.19282398.s8.e1" text="CsA" /><pair ddi="false" e1="DDI-PubMed.19282398.s8.e0" e2="DDI-PubMed.19282398.s8.e0" /><pair ddi="false" e1="DDI-PubMed.19282398.s8.e0" e2="DDI-PubMed.19282398.s8.e1" /></sentence><sentence text=" Thus, we can conclude that CsA modulates the transporter function sustainably"><entity charOffset="28-30" id="DDI-PubMed.19282398.s9.e0" text="CsA" /></sentence><sentence text=" It can cause a potent in vivo drug-drug interaction" /><sentence text=" The modulation of transporters is not caused by reduced expression or driving force of transporters" /><sentence text=" It may be affected by CsA accumulated in the liver or its metabolites"><entity charOffset="23-25" id="DDI-PubMed.19282398.s12.e0" text="CsA" /></sentence><sentence text=" The inhibitory effect of CsA on the transporter-mediated uptake of BSP cannot be explained by a simple competitive mechanism and a novel mechanism should be considered"><entity charOffset="26-28" id="DDI-PubMed.19282398.s13.e0" text="CsA" /></sentence><sentence text="" /></document>